Menu
 
Research menu
Jump to menu

Publications:  Dr Klaus Schmierer

Campion T, Smith RJP, Altmann DR et al. (2017) . FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?.Eur Radiol
10.1007/s00330-017-4822-z
Giovannoni G, Cutter G, Pia-Sormani M et al. (2017) . Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.Mult Scler Relat Disord vol. 12, 70-78.
10.1016/j.msard.2017.01.007
Albor C, du Sautoy T, Kali Vanan N et al. (2017) . Ethnicity and prevalence of multiple sclerosis in east London.Mult Scler vol. 23, (1) 36-42.
10.1177/1352458516638746
http://qmro.qmul.ac.uk/xmlui/handle/123456789/13579
Stavrou M, Smith D, Shaw P et al. (2016) . REAL WORLD EXPERIENCE OF FINGOLIMOD IN MULTIPLE SCLEROSIS: THE LONDON AUDIT. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 87,
10.1136/jnnp-2016-315106.160
Davis A, Turner B, Ramadhan M et al. (2016) . THE BURDEN OF BLADDER DYSFUNCTION IN MULTIPLE SCLEROSIS: A MULTI-CENTRE AUDIT. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 87,
10.1136/jnnp-2016-315106.127
Pakpoor J, Wotton CJ, Schmierer K et al. (2016) . Gender identity disorders and multiple sclerosis risk: A national record-linkage study.MULTIPLE SCLEROSIS JOURNAL vol. 22, (13) 1759-1762.
10.1177/1352458515627205
Pakpoor J, Wotton CJ, Schmierer K et al. (2016) . Gender identity disorders and multiple sclerosis risk: A national record-linkage study. Mult Scler. vol. 22, 1759-1762.
10.1177/1352458515627205
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11114
Thomson A, Giovannoni G, Marta M et al. (2016) . Importance of upper limb function in advanced multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL. vol. 22, 676-676.
Rejdak K, Mitosek-Szewczyk K, Prus K et al. (2016) . Induction therapy of relapsing secondary multiple sclerosis using generic cladribine. MULTIPLE SCLEROSIS JOURNAL. vol. 22, 593-594.
Gold J, Marta MC, Meier UC et al. (2016) . Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study biomarker outcome results. MULTIPLE SCLEROSIS JOURNAL. vol. 22, 188-189.
Marta M, MacManus D, Yousry T et al. (2016) . Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study results. MULTIPLE SCLEROSIS JOURNAL. vol. 22, 188-188.
Pakpoor J, Goldacre R, Schmierer K et al. (2016) . Risks of psychiatric disorders in children and young adults with demyelinating diseases of the central nervous system: a national record-linkage study. MULTIPLE SCLEROSIS JOURNAL. vol. 22, 17-17.
Petrova N, Carassiti D, Scaravilli F et al. (2016) . Synaptic loss in the MS spinal cord: a key driver of disease progression?. MULTIPLE SCLEROSIS JOURNAL. vol. 22, 80-80.
Alvarez-Gonzalez C, Allen-Philbey K, Mathews J et al. (2016) . Treating multiple sclerosis with generic cladribine. MULTIPLE SCLEROSIS JOURNAL. vol. 22, 604-605.
Campion T, Schmierer K (2016) . Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.Clinical Radiology
10.1016/j.crad.2016.05.021
http://qmro.qmul.ac.uk/xmlui/handle/123456789/13800
Raftopoulos R, Hickman SJ, Toosy A et al. (2016) . Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.Lancet Neurol vol. 15, (3) 259-269.
10.1016/S1474-4422(16)00004-1
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11119
Davis A, Dobson R, Kaninia S et al. (2016) . Atraumatic needles for lumbar puncture: why haven't neurologists changed?.Pract Neurol vol. 16, (1) 18-22.
10.1136/practneurol-2014-001055
http://qmro.qmul.ac.uk/xmlui/handle/123456789/10032
Dobson R, Ramagopalan S, Topping J et al. (2016) . A Risk Score for Predicting Multiple Sclerosis.PLoS One vol. 11, (11)
10.1371/journal.pone.0164992
http://qmro.qmul.ac.uk/xmlui/handle/123456789/18832
Pakpoor J, Disanto G, Altmann DR et al. (2015) . No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.Neurol Neuroimmunol Neuroinflamm vol. 2, (6)
10.1212/NXI.0000000000000158
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12681
Thomson A, Davis A, Paterson A et al. (2015) . DESIGNING AN INFORMATION RESOURCE TO EXPLAIN DIAGNOSTIC LUMBAR PUNCTURE AND PROMOTE BEST PRACTICE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 86,
10.1136/jnnp-2015-312379.3
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11116
Albor C, du Sautoy T, Vanan NK et al. (2015) . ETHNICITY AND MULTIPLE SCLEROSIS PREVALENCE IN EAST LONDON. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 86,
10.1136/jnnp-2015-312379.100
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11117
Carassiti D, Pakkenberg B, Scaravilli F et al. (2015) . Cortical atrophy predicts neuronal loss in MS: a post mortem study using unbiased sampling. MULTIPLE SCLEROSIS JOURNAL. vol. 21, 423-424.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11115
Giovannoni G, Brex P, Sumra M et al. (2015) . Glatiramer acetate slows disability progression - results from a 6-year analysis of the UK Risk Sharing Scheme. MULTIPLE SCLEROSIS JOURNAL. vol. 21, 800-801.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11118
Raftopoulos R, Rangarajan A, Chen C-L et al. (2015) . Sodium channel blockade with phenytoin has a neuroprotective effect on the ganglion cell complex after acute optic neuritis. MULTIPLE SCLEROSIS JOURNAL. vol. 21, 273-274.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12094
Scolding N, Barnes D, Cader S et al. (2015) . Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.Pract Neurol vol. 15, (4) 273-279.
10.1136/practneurol-2015-001139
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11980
Giovannoni G, Turner B, Gnanapavan S et al. (2015) . Is it time to target no evident disease activity (NEDA) in multiple sclerosis?.Mult Scler Relat Disord vol. 4, (4) 329-333.
10.1016/j.msard.2015.04.006
http://qmro.qmul.ac.uk/xmlui/handle/123456789/8421
Thomson A, Davis A, Paterson A et al. (2015) . Designing an information resource to explain diagnostic lumbar puncture and promote best practice. EUROPEAN JOURNAL OF NEUROLOGY. vol. 22, 491-492.
Raftopoulos R, Hickman S, Toosy A et al. (2015) . Neuroprotection with phenytoin in acute optic neuritis: results of a phase II randomised controlled trial. EUROPEAN JOURNAL OF NEUROLOGY. vol. 22, 48-48.
Raciborska D, Turner B, Schmierer K (2015) . Switching MS patients from natalizumab to fingolimod therapy: comparison of short and prolonged washout periods. EUROPEAN JOURNAL OF NEUROLOGY. vol. 22, 350-350.
Schmierer K (2015) . New Perspectives on Inflammatory CNS Disease Therapies. MULTIPLE SCLEROSIS JOURNAL. vol. 21, 802-803.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7799
Schmierer K (2015) . Pathological and MRI markers of deterioration.MULTIPLE SCLEROSIS JOURNAL vol. 21, (6) 799-800.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9630
Giovannoni G, Baker D, Schmierer K (2015) . The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?.Mult Scler Relat Disord vol. 4, (1) 3-5.
10.1016/j.msard.2014.11.005
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11979
Pakpoor J, Goldacre R, Schmierer K et al. (2014) . Testicular hypofunction and multiple sclerosis: Cause or consequence? Reply.Ann Neurol vol. 76, (5) 765-766.
10.1002/ana.24275
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7243
Pakpoor J, Disanto G, Altmann DR et al. (2014) . CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 85,
10.1136/jnnp-2014-309236.140
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7246
Schmierer K, Marta M, Turner BP et al. (2014) . THE USE OF MAGNETIC RESONANCE IMAGING (MRI) IN THE MANAGEMENT OF MULTIPLE SCLEROSIS IN THE UK. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 85,
10.1136/jnnp-2014-309236.131
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7245
Pakpoor J, Goldacre R, Schmierer K et al. (2014) . Testicular hypofunction and multiple sclerosis risk: a record-linkage study.Ann Neurol vol. 76, (4) 625-628.
10.1002/ana.24250
http://qmro.qmul.ac.uk/xmlui/handle/123456789/6339
Giovannoni G, Baker D, Schmierer K (2014) . Simvastatin in patients with progressive multiple sclerosis.Lancet vol. 384, (9947)
10.1016/S0140-6736(14)61621-4
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11982
Campion T, Smith P, Altmann DR et al. (2014) . FLAIR* for the non-invasive histological diagnosis of MS. MULTIPLE SCLEROSIS JOURNAL. vol. 20, 289-290.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12022
Carassiti D, Papachatzaki M, Scaravilli F et al. (2014) . The loss of neurons over the whole MS neocortex. MULTIPLE SCLEROSIS JOURNAL. vol. 20, 59-59.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9629
Carassiti D, Petrova N, Al-Zawawi S et al. (2014) . The relationship between axonal loss and demyelination in the MS spinal cord. MULTIPLE SCLEROSIS JOURNAL. vol. 20, 366-366.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/8024
Gnanapavan S, Jaunmuktane Z, Baruteau KP et al. (2014) . A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.BMC Neurol vol. 14,
10.1186/1471-2377-14-68
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7244
Wallner-Blazek M, Rovira A, Filippi M et al. (2014) . Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.J Neurol vol. 261, (4) 848-849.
10.1007/s00415-014-7279-x
Altmann DR, Button T, Schmierer K et al. (2014) . Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis.Mult Scler Relat Disord vol. 3, (2) 237-243.
10.1016/j.msard.2013.09.007
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11981
Davis A, Dobson R, Kaninia S et al. (2014) . Change practice now! Using atraumatic needles to prevent post lumbar puncture headache.Eur J Neurol vol. 21, (2) 305-311.
10.1111/ene.12307
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12000
Dobson R, Rudick RA, Turner B et al. (2014) . Assessing treatment response to interferon-beta Is there a role for MRI?.NEUROLOGY vol. 82, (3) 248-254.
10.1212/WNL.0000000000000034
Dobson R, Rudick RA, Turner B et al. (2014) . Assessing treatment response to interferon-β: is there a role for MRI?.Neurology vol. 82, (3) 248-254.
10.1212/WNL.0000000000000036
Papachatzaki MM, Ali N, Arshad Q et al. (2013) . Progressive ataxia with oculo-palatal tremor and optic atrophy.J Neurol vol. 260, (11) 2903-2905.
10.1007/s00415-013-7136-3
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9611
Albor C, Richards O, Ramagopalan S et al. (2013) . Using routine point-of-care data for research: the East london multiple sclerosis cohort.J Neurol Neurosurg Psychiatry vol. 84, (11)
10.1136/jnnp-2013-306573.170
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7384
Carassiti D, Papachatzaki M, Scaravilli F et al. (2013) . Accurate estimates of whole brain neuronal loss in multiple sclerosis using unbiased quantitative histology. MULTIPLE SCLEROSIS JOURNAL. vol. 19, 161-161.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7241
Raftopoulos RE, Hickman S, Toosy A et al. (2013) . Optical coherence tomography (OCT), visual function and MRI measures in acute optic neuritis: baseline data from a clinical trial. MULTIPLE SCLEROSIS JOURNAL. vol. 19, 8-9.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9614
Papachatzaki MM, Carassiti D, McDowell A et al. (2013) . Stereological estimates of neuronal loss in the primary motor cortex of multiple sclerosis patients. MULTIPLE SCLEROSIS JOURNAL. vol. 19, 571-572.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7240
Wallner-Blazek M, Rovira A, Fillipp M et al. (2013) . Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.J Neurol vol. 260, (8) 2016-2022.
10.1007/s00415-013-6918-y
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7239
Schmierer K, Papachatzaki MM (2013) . A single lesion-And yet MS?.Mult Scler Relat Disord vol. 2, (3) 154-155.
10.1016/j.msard.2013.02.002
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11978
Yiannakas MC, Tozer DJ, Schmierer K et al. (2013) . ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.Mult Scler vol. 19, (6) 732-741.
10.1177/1352458512462074
http://qmro.qmul.ac.uk/xmlui/handle/123456789/10911
Valdueza JM, Doepp F, Schreiber SJ et al. (2013) . What went wrong? The flawed concept of cerebrospinal venous insufficiency.J Cereb Blood Flow Metab vol. 33, (5) 657-668.
10.1038/jcbfm.2013.31
http://qmro.qmul.ac.uk/xmlui/handle/123456789/10910
Papachatzaki MM, Ali N, Peppas Y et al. (2012) . A NEW PHENOTYPE OF PAPT: PROGRESSIVE ATAXIA, PALATAL TREMOR AND OPTIC ATROPHY. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2012-304200a.52
Mougin OE, Mistry N, Papachatzaki MM et al. (2012) . MULTI-MODAL MRI AT 7T TO DETECT AND QUANTIFY MULTIPLE SCLEROSIS CORTICAL GREY MATTER PATHOLOGY. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2012-304200a.137
Davis A, Espasandin MD, Schmierer K (2012) . OVER 100 YEARS OF POST LUMBAR PUNCTURE HEADACHE, AND COUNTING. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2012-304200a.24
Raftopoulos RE, Hickman S, Toosy A et al. (2012) . A phase II double-blind, randomised, placebo-controlled trial of neuroprotection with phenytoin in acute optic neuritis. MULTIPLE SCLEROSIS JOURNAL. vol. 18, 442-443.
Davis A, Dobson R, Espasandin M et al. (2012) . Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches. MULTIPLE SCLEROSIS JOURNAL. vol. 18, 237-238.
Dobson R, Meier UC, Schmierer K et al. (2012) . DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 83,
10.1136/jnnp-2011-301993.173
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7015
Kappos L, Gold R, Miller DH et al. (2012) . Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.Mult Scler vol. 18, (3) 314-321.
10.1177/1352458511421054
SCHMIERER K (2012) . Magnetic resonance imaging in multiple sclerosis.Multiple Sclerosis (Visual Guide for Clinicians), Editors: Dobson, R, Giovannoni, G, Atlas Medical Publishing
Petzold A, Tozer DJ, Schmierer K (2011) . Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter.Exp Neurol vol. 232, (2) 234-239.
10.1016/j.expneurol.2011.09.011
Dobson R, Meier UC, Schmierer K et al. (2011) . Do siblings have markers of multiple sclerosis risk?.MULTIPLE SCLEROSIS JOURNAL vol. 17, S86-S86.
Schmierer K, Tozer D, Petzold A (2011) . In multiple sclerosis' protein phosphorylation competes with the free proton binding capacity in post-mortem brain tissue.MULTIPLE SCLEROSIS JOURNAL vol. 17, S503-S503.
Schmierer K, Tozer DJ, Petzold A (2011) . Axonal Damage in the Making: Neurofilament Phosphorylation and Magnetization Transfer in Multiple Sclerosis Non-Lesional White Matter. NEUROLOGY. vol. 76, A358-A358.
MacManus DG, Miller DH, Kappos L et al. (2011) . BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis.J Neurol vol. 258, (3) 449-456.
10.1007/s00415-010-5777-z
Connolly F, Paul F, Valdueza JM et al. (2011) . Patients with Multiple Sclerosis Do Not Suffer from Cerebro-Cervical Venous Congestion. NEUROLOGY. vol. 76, A171-A171.
Ugradar SY, Parkes H, So PW et al. (2011) . Quantifying Remyelination in Multiple Sclerosis Using High Field (9.4T) Magnetic Resonance Imaging. NEUROLOGY. vol. 76, A172-A172.
Schmierer K (2010) . Imaging of human inflammatory neurodegenerative disorders. IMMUNOLOGY. vol. 131, 5-5.
Doepp F, Paul F, Valdueza JM et al. (2010) . Reply.Ann Neurol vol. 68, (6)
10.1002/ana.22182
Schmierer K, Thavarajah JR, An SF et al. (2010) . Effects of formalin fixation on magnetic resonance indices in multiple sclerosis cortical gray matter.J Magn Reson Imaging vol. 32, (5) 1054-1060.
10.1002/jmri.22381
Doepp F, Paul F, Valdueza JM et al. (2010) . Multiple Sclerosis Appears To Be Associated with Cerebral Venous Abnormalities Reply.ANN NEUROL vol. 68, (4) 561-562.
10.1002/ana.22181
Doepp F, Paul F, Valdueza JM et al. (2010) . No cerebrocervical venous congestion in patients with multiple sclerosis.Ann Neurol vol. 68, (2) 173-183.
10.1002/ana.22085
Schmierer K, Parkes HG, So P-W et al. (2010) . High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.Brain vol. 133, (Pt 3) 858-867.
10.1093/brain/awp335
Schmierer K (2009) . HIGH FIELD MRI REVEALS MULTIPLE SCLEROSIS CORTICAL GREY MATTER LESIONS AND ALLOWS QUANTITATIVE ASSESSMENT OF NEURONS AND AXONS. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 80,
10.1136/jnnp.2009.195180w
Parkes H, So PW, Brandner S et al. (2009) . Quantifying cortical pathology in multiple sclerosis using high-field MRI. MULTIPLE SCLEROSIS. vol. 15, S91-S91.
Farrell RA, Antony D, Wall GR et al. (2009) . Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.NEUROLOGY vol. 73, (1) 32-38.
10.1212/WNL.0b013e3181aa29fe
Fisniku LK, Altmann DR, Cercignani M et al. (2009) . Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.Mult Scler vol. 15, (6) 668-677.
10.1177/1352458509103715
Goodman AD, Rossman H, Bar-Or A et al. (2009) . GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.Neurology vol. 72, (9) 806-812.
10.1212/01.wnl.0000343880.13764.69
Schmierer K, Parkes HG, So P-W (2009) . Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI.Neurology vol. 72, (5)
10.1212/01.wnl.0000341878.80395.39
Schmierer K (2008) . Commentary on: "Dirty-appearing white matter in multiple sclerosis.J NEUROL vol. 255, (11) 1812-1812.
10.1007/s00415-008-0001-0
Schmierer K (2008) . Commentary on: "Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss", by G. R. W. Moore, et al. in J Neurol (2008) 255: DOI 10.1007/s00415-008-0002-z.J Neurol vol. 255, (11)
Kappos L, Gold R, Miller DH et al. (2008) . Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.Lancet vol. 372, (9648) 1463-1472.
10.1016/S0140-6736(08)61619-0
Petzold A, Gveric D, Groves M et al. (2008) . Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology.Exp Neurol vol. 213, (2) 326-335.
10.1016/j.expneurol.2008.06.008
Parkes H, Shorter S, So PW et al. (2008) . High resolution 1H nuclear magnetic resonance spectroscopic-based metabolomic urine analysis of experimental autoimmune encephalitis, a model disease of multiple sclerosis. MULTIPLE SCLEROSIS. vol. 14, S86-S87.
Schmierer K, Parkes H, So PW et al. (2008) . Magnetization transfer ratio: a predictor of neuronal loss in multiple sclerosis cortical gray matter?. MULTIPLE SCLEROSIS. vol. 14, S219-S220.
Schmierer K, Thavarajah JR, Parkes H et al. (2008) . Multiple sclerosis cortical grey matter changes following fixation detected by multimodal magnetic resonance imaging. MULTIPLE SCLEROSIS. vol. 14, S220-S220.
MacManus DG, Miller D, Kappos L et al. (2008) . The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions. MULTIPLE SCLEROSIS. vol. 14, S163-S163.
Kappos L, Miller D, MacManus D et al. (2008) . The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study. NEUROLOGY. vol. 70, A83-A83.
Schmierer K, Wheeler-Kingshott CAM, Tozer DJ et al. (2008) . Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation.Magn Reson Med vol. 59, (2) 268-277.
10.1002/mrm.21487
Tofts PS, Jackson JS, Tozer DJ et al. (2008) . Imaging cadavers: cold FLAIR and noninvasive brain thermometry using CSF diffusion.Magn Reson Med vol. 59, (1) 190-195.
10.1002/mrm.21456
Schmierer K, Meara SJP, Miller DH et al. (2007) . 3D inversion recovery fast spin echo for lesion detection in post mortem multiple sclerosis brain. MULTIPLE SCLEROSIS. vol. 13, S77-S77.
Parkes HG, So PW, Miller DH et al. (2007) . High field (9.4T) magnetic resonance reveals cortical lesions in multiple sclerosis brain. MULTIPLE SCLEROSIS. vol. 13, S72-S73.
Parkes HG, Denham M, Schmierer K (2007) . High-resolution 1H NMR spectroscopy of multiple sclerosis brain. MULTIPLE SCLEROSIS. vol. 13, S251-S252.
Schmierer K, Tozer DJ, Scaravilli F et al. (2007) . Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain.J Magn Reson Imaging vol. 26, (1) 41-51.
10.1002/jmri.20984
Schmierer K, Wheeler-Kingshott CAM, Boulby PA et al. (2007) . Diffusion tensor imaging of post mortem multiple sclerosis brain.Neuroimage vol. 35, (2) 467-477.
10.1016/j.neuroimage.2006.12.010
Kappos L, Gold R, Miller D et al. (2007) . Safety and tolerability results of a phase 2b extension study of the novel oral fumarate BG00012 for the treatment of relapsing-remitting multiple sclerosis. NEUROLOGY. vol. 68, A276-A277.
Schmierer K, Miller DH (2006) . Making sense of magnetic resonance measures in multiple sclerosis: The post mortem evidence. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 77, 1389-1389.
Kappos L, Miller DH, MacManus DG et al. (2006) . BG00012, a novel oral fumarate, is effective in patients with relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS. vol. 12, S85-S85.
Schmierer K, Parkes HG, So PW et al. (2006) . High field-high yield: detecting multiple sclerosis white matter lesions at 9.4 Tesla. MULTIPLE SCLEROSIS. vol. 12, S45-S45.
Kappos L, Miller DH, MacManus DG et al. (2006) . Efficacy of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remitting multiple sclerosis: results of a phase 2 study. JOURNAL OF NEUROLOGY. vol. 253, 27-27.
Symms M, Jäger HR, Schmierer K et al. (2006) . A review of structural magnetic resonance neuroimaging.Neuroscience for Neurologists,
Schmierer K, Tozer DJ, Boulby PA et al. (2005) . Changes of quantitative magnetic resonance indices following fixation in post-mortem MS brain. MULTIPLE SCLEROSIS. vol. 11, S141-S141.
Schmierer K, Tozer DJ, Scaravilli F et al. (2005) . Short T2 relaxation: a potential marker of myelin in post-mortem multiple sclerosis brain. MULTIPLE SCLEROSIS. vol. 11, S141-S141.
Cercignani M, Symms MR, Schmierer K et al. (2005) . Three-dimensional quantitative magnetisation transfer imaging of the human brain.Neuroimage vol. 27, (2) 436-441.
10.1016/j.neuroimage.2005.04.031
Lim ET, Schmierer K, Grant D et al. (2005) . A comparison of the immunology and histopathology in post mortem multiple sclerosis brain. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 76, 615-616.
Symms M, Jäger HR, Schmierer K et al. (2004) . A review of structural magnetic resonance neuroimaging.J Neurol Neurosurg Psychiatry vol. 75, (9) 1235-1244.
10.1136/jnnp.2003.032714
Schmierer K, Scaravilli E, Tozer DJ et al. (2004) . Magnetisation transfer as a tool to monitor multiple sclerosis: postmortem evidence. MULTIPLE SCLEROSIS. vol. 10, S229-S229.
Schmierer K, Scaravilli F, Altmann DR et al. (2004) . Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain.Ann Neurol vol. 56, (3) 407-415.
10.1002/ana.20202
Schmierer K, Scaravilli E, Boulby P et al. (2004) . Pathological correlates of diffusion tenser imaging (DTI) in post-mortem MS brain. MULTIPLE SCLEROSIS. vol. 10, S229-S229.
Schmierer K (2004) . Pathological substrates of quantitative MRI in post mortem multiple sclerosis brain. MULTIPLE SCLEROSIS. vol. 10, S104-S105.
Goodman A, Bar-Or A, Miller A et al. (2004) . GLANCE: A double-blind, randomised, placebo-controlled, parallel-group safety study of natalizumab (Antegren) in combination with glatiramer acetate (Copaxone) in subjects with relapsing-remitting multiple sclerosis. JOURNAL OF NEUROLOGY. vol. 251, 176-177.
Schmierer K, Scaravilli E, Altmann DA et al. (2004) . Magnetisation transfer ratio: a robust measure of myelin content in post-mortem multiple sclerosis brain. JOURNAL OF NEUROLOGY. vol. 251, 24-24.
Kuhle J, Hardmeier M, Hooghe MD et al. (2004) . 8 year follow-up of the European study of Interferon beta-1b (EUSPMS) in secondary progressive MS.NEUROLOGY vol. 62, (7) A489-A490.
Schmierer K, Altmann DR, Kassim N et al. (2004) . Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study.Mult Scler vol. 10, (2) 182-187.
10.1191/1352458504ms996oa
Schmierer K, Scaravilli F, Barker GJ et al. (2003) . Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brain.Neuropathol Appl Neurobiol vol. 29, (6) 596-601.
10.1046/j.1365-2990.2003.0497.x
Mottershead JP, Schmierer K, Clemence M et al. (2003) . High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord.J Neurol vol. 250, (11) 1293-1301.
10.1007/s00415-003-0192-3
Grosse P, Schulz J, Schmierer K (2003) . Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis.Lancet Neurol vol. 2, (8)
10.1016/S1474-4422(03)00488-5
Schreiber SJ, Doepp F, Bender A et al. (2003) . Diffuse cerebral angiomatosis.Neurology vol. 60, (7) 1216-1218.
10.1212/01.WNL.0000055923.78277.9C
Dobson-Stone C, Danek A, Rampoldi L et al. (2002) . Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis.EUR J HUM GENET vol. 10, (11) 773-+.
10.1038/sj/ejhg.5200866
Dobson-Stone C, Danek A, Rampoldi L et al. (2002) . Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis.Eur J Hum Genet vol. 10, (11) 773-781.
10.1038/sj.ejhg.5200866
Schmierer K, Irlbacher K, Grosse P et al. (2002) . Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation.Neurology vol. 59, (8) 1218-1224.
10.1212/WNL.59.8.1218
Schmierer K, Grosse P, De Camilli P et al. (2002) . Paraneoplastic stiff-person syndrome: no tumor progression over 5 years.Neurology vol. 58, (1)
10.1212/WNL.58.1.148
Schmierer K (2002) . [Medical history and politics: careers of Fritz Lejeune during the Weimar Republic and national socialism].Abh Gesch Med Naturwiss (96) 1-292.
Schmierer K, Niehaus L, Röricht S et al. (2000) . Conduction deficits of callosal fibres in early multiple sclerosis.J Neurol Neurosurg Psychiatry vol. 68, (5) 633-638.
10.1136/jnnp.68.5.633
Wendling U, Aktas O, Schmierer K et al. (2000) . Partial synergy of bisindolylmaleimide with apoptotic stimulus in antigen-specific T cells--implications for multiple sclerosis.J Neuroimmunol vol. 103, (1) 69-75.
10.1016/S0165-5728(99)00214-3
Meyer BU, Röricht S, Schmierer K et al. (1999) . First diagnostic applications of transcallosal inhibition in diseases affecting callosal neurones (multiple sclerosis, hydrocephalus, Huntington's disease). Electroencephalogr Clin Neurophysiol Suppl. vol. 51, 233-242.
Kappos L, Polman C, Pozzilli C et al. (1998) . Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis.LANCET vol. 352, (9139) 1491-1497.
10.1016/S0140-6736(98)10039-9
Schmierer K, Valdueza JM, Bender A et al. (1998) . Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression.Neurology vol. 51, (1) 250-252.
10.1212/WNL.51.1.250
Schmierer K, Roricht S, Niehaus L et al. (1998) . Impaired transcallosal inhibition: an early indicator of central conduction deficits in multiple sclerosis. 9TH EUROPEAN CONGRESS OF CLINICAL NEUROPHYSIOLOGY. Editors: Stalberg, EV, DeWeerd, AW, Zidar, J, 119-123.
Meyer BU, Niehaus L, Petrow E et al. (1998) . Inhibitory effects of transcranial magnetic motor cortex stimulation in man. 9TH EUROPEAN CONGRESS OF CLINICAL NEUROPHYSIOLOGY. Editors: Stalberg, EV, DeWeerd, AW, Zidar, J, 83-88.
Valdueza JM, Schmierer K, Mehraein S et al. (1996) . Assessment of normal flow velocity in basal cerebral veins. A transcranial doppler ultrasound study.Stroke vol. 27, (7) 1221-1225.
10.1161/01.STR.27.7.1221
BAKER D, Schmierer K. Axonal loss in the multiple sclerosis spinal cord revisited.Brain Pathology
10.1111/bpa.12516
SCHMIERER K, Albor C, du Sautoy T et al.. Ethnicity and prevalence of multiple sclerosis in east London.Multiple Sclerosis Journal
10.1177/1352458516638746
http://qmro.qmul.ac.uk/xmlui/handle/123456789/14965
BAKER D, Marta M, Pryce G et al.. Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.eBiomedicne
10.1016/j.ebiom.2017.01.042
Giovannoni G, Marta M, Davis A et al.. Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.Practical Neurologypractneurol-2015-001-practneurol-2015-001.
10.1136/practneurol-2015-001355
http://qmro.qmul.ac.uk/xmlui/handle/123456789/14950
Return to top